Tait H Huso

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

L. Resar, L. Xian, L. Resar, 2016, Current molecular medicine.

HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis

J. Kowalski, D. Huso, L. Resar, 2011, BMC Genomics.

The high mobility group A1 molecular switch: turning on cancer – can we turn it off?

L. Resar, T. Huso, Tait H Huso, 2014, Expert opinion on therapeutic targets.

HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche

L. Cope, L. Resar, A. Ewald, 2017, Nature Communications.

The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.

L. Cope, L. Resar, L. Xian, 2016, Gynecologic oncology.

The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

L. Cope, A. Maitra, L. Resar, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation

L. Cope, L. Xian, I. Herrera, 2023, The Journal of clinical investigation.

Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.

L. Cope, L. Resar, R. Reeves, 2016, Journal of proteome research.

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

J. Turkson, L. Resar, L. Xian, 2016, Leukemia & lymphoma.

HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis.

L. Resar, R. Reeves, D. Gang, 2015, Journal of proteome research.